BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 13.3//EN BEGIN:VTIMEZONE TZID:UTC BEGIN:STANDARD DTSTART;VALUE=DATE:20250101 TZNAME:UTC TZOFFSETFROM:+0000 TZOFFSETTO:+0000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:Date: Thursday 3rd July 2025\nTime: 09:30 \;- 17:30 BST\nLo cation: \;The Hub - AstraZeneca\, Biomedical Campus\, 1 Francis Crick Ave\, Trumpington\, Cambridge CB2 0AA\, United Kingdom\n\nWho is this even t intended for?: Anyone interested in the practicalities of moving to R/op en-source (covering all levels and types of statistician/programmer)\n\nWh at is the benefit of attending?: \;\n\n To hear how a wide range of companies have approached moving to R/Open source.\n To focus on and d iscuss all of the particular topics of change management in this space.\n To be sent away well equipped to have the conversations about change ma nagement within your particular context.\n\nOverview\nThis one-day event f ocuses on the comprehensive management of transitioning to R/Open-Source\, addressing the challenges and providing actionable insights. Attendees wi ll participate in sessions covering essential topics such as training best practices\, creating strategic plans\, making the case to senior manageme nt\, and managing both statistical and programming aspects of the transiti on. The day includes presentations from industry leaders\, interactive dis cussions (including a panel discussion)\, and networking opportunities\, a imed at equipping decision-makers\, leaders\, statisticians\, and programm ers with the tools needed to navigate and implement this significant chang e effectively.\n\nTransitioning to R/Open-Source represents a large\, comp lex\, and potentially chaotic change\, often characterized by fear\, uncer tainty\, and doubt. There are often numerous discussions around specifics (R validation\, Shiny applications\, and regulatory submission) or larger pharma companies talking about their specific move to R\, but not much in the way of focusing on each of the particular topics of change management in this space and applying this to different sizes and types of companies so all can fully benefit.\nDive into this one-day event with comprehensive sessions covering essential topics such as:\n\n Best way to train\n Creating a vision and plans\n Making the case to senior management\n How to address statistical aspects (Equivalency of methods\, availabilit y of functionality\, comparability\, Stat Analysis Plans\, QC)\n Progra mming specific aspects (Environment\, existing code base\, validation)\n Find your change agents\n Dealing with strong feelings during a signi ficant change (fast pace\, fear\, overexcitement\, instability)\n\nWhether you&rsquo\;re a decision-maker\, leader\, methodological statistician\, o r keen programmer\, this event is designed to equip you with the knowledge and tools needed to approach this transition. Come and be part of an inte ractive day\, share experiences\, and hear from other companies about how they are managing the change. Go home knowing how to approach this change and how to initiate conversations with colleagues and management. Register now to secure your spot and take steps towards embracing open-source solu tions confidently!\nCost\nThis in-person event is free to both Members of PSI and Non-Members and includes lunch and refreshments.\nRegistration\nTo register for this event\, please \;click here.\nSpeaker details\n\n\n \n\n \n \n \n Speaker\n \n \n Biography\n \n \n A bstract Title\n \n \n \n \n \n \n \n Mike Smith\, Pfizer\n \n Mike K Smith is a senior director and lead of the R Centre of Excellence at Pfizer where he has worked for 32 years. Like many other pharma companies\, Pfizer is making the transition towards using R as the backbone of clinical trial reporting\, but they have been using R in vari ous areas for about 20 years. In Mike&rsquo\;s role as a subject matter ex pert and champion for R over this time\, he has had a lead role in definin g validation\, training\, building community and supporting colleagues &nd ash\; approximately 1300 Pfizer staff are on the &ldquo\;R in Pfizer&rdquo \; Teams channel. He is also a veteran of supporting colleagues through ro ll out of new tools and systems so has first-hand experience of leading bu siness input to change management.\n \n Introducing Change Management \;\n \n \n \n An dy Nicholls\, GSK\n \n  \;\n \n \n Andy Nicholls is a Senior Director and Head of GSK&rsq uo\;s Data Science Innovation and Engineering team where he is responsible for setting and delivering Biostatistics&rsquo\; open-source strategy and R adoption objective. Over the past 8 years at GSK\, Andy and his team ha ve led a global R training program\, delivered GSK&rsquo\;s first dedicate d platform for R\, and built a new wave of tooling to support new programm ing delivery concepts such as Analysis Results Data. \; \;\n \n \n \n From Training to Practice : A shift to Just in Time User Support\n \n \n \n \n \n Martin Brown\, PPD\n \n  \;\n \n \n Martin Brown is an Associate Director in PPD&rsquo\;s Statistical Science group having joined PPD in 2007. In this role he consults on various areas\, including complex statistical methods\, simulations\, and statistical software\, and is leading the transition towards using R. He received his MSc. in Statis tics from the University of Sheffield and is a Chartered Statistician with the RSS. Martin is also the chair of the PSI AIMS special interest group\ , which aims to support statisticians in moving to open source.\n \n \n \n Change management in a large CRO\; investing for the future\n  \;\n  \;\ n \n \n \n \n \n \n Stuart Malcolm\, Veramed\n \n \n \n Planning on R? Risks\, Resources and Realism\n \n \n \n \n \n Yannick Vandendijck\, Johnson &\; Johnson\n \n Yannick V andendijck is a biostatistician at Johnson &\; Johnson since 2018. He o btained his PhD at Hasselt University (Belgium) in 2015. Within Johnson &a mp\; Johnson\, Yannick has worked mainly on early development studies in o ncology\, global public health\, and infectious diseases and vaccines. Yan nick contributed to and led multiple R initiatives within the Johnson & \; Johnson Statistics and Decision Sciences organisation\, such as initiat ives around the use of ggplot\, machine learning in R\, multiple R introdu ction trainings\, teal and efficacy analysis implementations in R. Yannick is an active contributor in the cross-pharma PHUSE DVOST CAMIS (Comparing Analysis Method Implementations in Software) working group. Further\, Yan nick is a guest professor at Hasselt University (Belgium).\n SA IL.R &ndash\; R in Biometrics - AstraZeneca approach to enable R Shiny app s for Drug Project activities\n \n \n \n \n \n Ruhul Amin\, AstraZeneca\n \n Ruhul is a Director\, Specialist Programming in Data Automation\, Clinical Data and Insights team at AstraZeneca. He has over 10 years&rsqu o\; experience in analysis and reporting of clinical trials within the pha rmaceutical industry\, across many different therapeutic areas. Ruhul is i nterested in system implementation\, automation and building efficiencies utilising the latest trends in programming technologies to support drug pr ojects. Today\, Ruhul is excited to share his experience on the implementa tion journey of enabling R Shiny apps for Biometrics use cases at AstraZen eca. Outside work\, Ruhul enjoys family &\; friend time and outdoor act ivities especially country cycling and hiking. Last year\, he climbed Scaf ell Pike and Mount Kilimanjaro.\n \n R in Biometrics - AstraZeneca approach to enable R Shiny apps for Drug Project activities \n \n \n \n \n \n \n Kieran Martin\, Roche\n \n  \;\n \n \n \n \n Getting Ready for submission with R\n  \;\n  \;\n \n \n \n \n \n Colin Gi llespie\, Jumping Rivers\n \n \n Colin ha s been using R since 1999. He is the CTO of Jumping Rivers and a Senior St atistics Lecturer at Newcastle University. \;\n Over the ye ars\, he&rsquo\;s written several R packages and published the book Effici ent R Programming with O&rsquo\;Reilly.\n \n \n Can I trust this package?\n \n \n \n \n Sebastià\; Barceló\;\, Cytel\n \n \n Sebastià\; Barceló\;\, Spanish (Ma llorca)\, Associate Director of Statistical Programming with more than 10 years of experience. He was involved in macro development and automation r elated tasks since the beginning of his career and he is now working in Ge neva within Cytel&rsquo\;s biometrics service department\, leading a group of developers in charge of several automation initiatives\, application d evelopment and driving Cytel&rsquo\;s transition to Open Source.\n \n \n Navigating Change in a CRO &ndash\; What I Wish I Knew 5 Years Ago About Transitioning to R\n \n \ n \n\n DTEND:20250703T173000Z DTSTAMP:20260310T003834Z DTSTART:20250703T093000Z LOCATION: SEQUENCE:0 SUMMARY:One-day Event: Change Management for Moving to R/Open-Source UID:RFCALITEM639086999140844243 X-ALT-DESC;FMTTYPE=text/html:Date: Thursday 3rd July 2025< br />\nTime: 09:30 \;- 17:30 BST
\nLocat ion: \;The Hub - AstraZeneca\, Biomedical Campus\, 1 Francis Crick Ave\, Trumpington\, Cambridge CB2 0AA\, United Kingdom
\n
\nWho is this event intended for?: Anyone interested in t he practicalities of moving to R/open-source (covering all levels and type s of statistician/programmer)
\n
\nWhat is the benefit o f attending?: \;
\n \n

Overview

\n

This one-day event focuses on the comprehensive management of transitioning to R/Open-Source \, addressing the challenges and providing actionable insights. Attendees will participate in sessions covering essential topics such as training be st practices\, creating strategic plans\, making the case to senior manage ment\, and managing both statistical and programming aspects of the transi tion. The day includes presentations from industry leaders\, interactive d iscussions (including a panel discussion)\, and networking opportunities\, aimed at equipping decision-makers\, leaders\, statisticians\, and progra mmers with the tools needed to navigate and implement this significant cha nge effectively.
\n
\nTransitioning to R/Open-Source repr esents a large\, complex\, and potentially chaotic change\, often characte rized by fear\, uncertainty\, and doubt. There are often numerous discussi ons around specifics (R validation\, Shiny applications\, and regulatory s ubmission) or larger pharma companies talking about their specific move to R\, but not much in the way of focusing on each of the particular topics of change management in this space and applying this to different sizes an d types of companies so all can fully benefit.

\n

Dive into this one-day event with comprehensive sessio ns covering essential topics such as:

\n\n

Whether y ou&rsquo\;re a decision-maker\, leader\, methodological statistician\, or keen programmer\, this event is designed to equip you with the knowledge a nd tools needed to approach this transition. Come and be part of an intera ctive day\, share experiences\, and hear from other companies about how th ey are managing the change. Go home knowing how to approach this change an d how to initiate conversations with colleagues and management. Register n ow to secure your spot and take steps towards embracing open-source soluti ons confidently!

\n

Cost

\n

This in-person event is free to bo th Members of PSI and Non-Members and includes lunch and refreshments.

\n

Registration

\n

To register for this event\, please \;click here.

\n

Sp eaker details

\n\n\n

\n
\n \n \n \n \n \n \n \n \ n \n \n \n \n \n \n \n \n \n \n \n

Martin Brown is an Associate Director in P PD&rsquo\;s Statistical Science group having joined PPD in 2007. In this r ole he consults on various areas\, including complex statistical methods\, simulations\, and statistical software\, and is leading the transition to wards using R. He received his MSc. in Statistics from the University of S heffield and is a Chartered Statistician with the RSS. Martin is also the chair of the PSI AIMS special interest group\, which aims to support stati sticians in moving to open source.

\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \ n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n
END:VEVENT END:VCALENDAR
\n

Speaker

\n 		\n

Biog raphy

\n 		\n

Abstract Title

\n
\n

\n
\n MikeSmith
\n Mike Smith\, Pfizer

\n 		Mike K Smith is a senior director and lead o f the R Centre of Excellence at Pfizer where he has worked for 32 years. L ike many other pharma companies\, Pfizer is making the transition towards using R as the backbone of clinical trial reporting\, but they have been u sing R in various areas for about 20 years. In Mike&rsquo\;s role as a sub ject matter expert and champion for R over this time\, he has had a lead r ole in defining validation\, training\, building community and supporting colleagues &ndash\; approximately 1300 Pfizer staff are on the &ldquo\;R i n Pfizer&rdquo\; Teams channel. He is also a veteran of supporting colleag ues through roll out of new tools and systems so has first-hand experience of leading business input to change management.\n Introducing Change Management \;
AndyNicholls
\n Andy Nicholls\, GSK
\n \n

 \;

\n 		\n

Andy Nicholls is a Senior Director and Head of G SK&rsquo\;s Data Science Innovation and Engineering team where he is respo nsible for setting and delivering Biostatistics&rsquo\; open-source strate gy and R adoption objective. Over the past 8 years at GSK\, Andy and his t eam have led a global R training program\, delivered GSK&rsquo\;s first de dicated platform for R\, and built a new wave of tooling to support new pr ogramming delivery concepts such as Analysis Results Data. \; \;

\n \n 		\n

From Training to Practice: A shift to Just in Time User Support

\n
\n MB Headshot
\n Martin Brown\, PPD
\n \n

 \;

\n 		\n

Change manageme nt in a large CRO\; investing for the future

\n  \;\n

 \;

\n
\n
\n \n

Stuart Malcolm\, Veramed

\n 		\n Planning on R? Risks\, Resources and Realism
\n
\n

yannickvandendijck
\n Yannick Vandendijck\, Johnson &\; Johnson

\n 		Yannick Vandendijck is a biostatistician a t Johnson &\; Johnson since 2018. He obtained his PhD at Hasselt Univer sity (Belgium) in 2015. Within Johnson &\; Johnson\, Yannick has worked mainly on early development studies in oncology\, global public health\, and infectious diseases and vaccines. Yannick contributed to and led multi ple R initiatives within the Johnson &\; Johnson Statistics and Decisio n Sciences organisation\, such as initiatives around the use of ggplot \, machine learning in R\, multiple R introduction trainings\, te al and efficacy analysis implementations in R. Yannick is an active c ontributor in the cross-pharma PHUSE DVOST CAMIS (Comparing Analysis Metho d Implementations in Software) working group. Further\, Yannick is a guest professor at Hasselt University (Belgium).SAIL.R &ndash\; R in Biometrics - AstraZeneca approach to enable R Sh iny apps for Drug Project activities\n
\n

RuhulAmin
\n Ruhul Amin\, AstraZeneca

\n 		Ruhul is a Director\, Specialist Programming in Data Automation\, Clinical Data and Insights team at Astra Zeneca. He has over 10 years&rsquo\; experience in analysis and reporting of clinical trials within the pharmaceutical industry\, across many differ ent therapeutic areas. Ruhul is interested in system implementation\, auto mation and building efficiencies utilising the latest trends in programmin g technologies to support drug projects. Today\, Ruhul is excited to share his experience on the implementation journey of enabling R Shiny apps for Biometrics use cases at AstraZeneca. Outside work\, Ruhul enjoys family & amp\; friend time and outdoor activities especially country cycling and hi king. Last year\, he climbed Scafell Pike and Mount Kilimanjaro.\n R in Biometrics - AstraZeneca appr oach to enable R Shiny apps for Drug Project activities
\n
\n Kieran Martin\, Roche< br />\n \n

 \;

\n 		\n \n

Getting Ready for submission with R

\n  \;\n

 \;

\n
\n

ColinGillespi e
\n Colin Gillespie\, Jumping Rivers

\n 		\n

Colin has been using R since 1999. He is the CTO of Jumping Rivers and a Senior Statistics Lecturer at Newcastle University. \;

\n

Over the years\, he&rsquo\;s written several R pa ckages and published the book Efficient R Programming with O&rsquo\;Reilly .

\n \n 		Can I trust this package?
\n

SebastiaBarcelo
\n Sebastià\; Barcel&oac ute\;\, Cytel

\n 		\n

Sebastià\; Barceló\;\, Spanish (Mallorca)\, Ass ociate Director of Statistical Programming with more than 10 years of expe rience. He was involved in macro development and automation related tasks since the beginning of his career and he is now working in Geneva within C ytel&rsquo\;s biometrics service department\, leading a group of developer s in charge of several automation initiatives\, application development an d driving Cytel&rsquo\;s transition to Open Source.

\n \n 		Nav igating Change in a CRO &ndash\; What I Wish I Knew 5 Years Ago About Tran sitioning to R
\n